On the other hand, miRNA-223 which targets glucose transporter type 4 (GLUT4), has also been found significantly upregulated in patients with type II diabetes mellitus (T2DM) and left ventricular heart dysfunction (LVD) in biopsies from the left ventricle. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.